Join MSAA for a Live Relapse Management Webinar in Honor of MS Awareness Month

Each year, March is nationally recognized as Multiple Sclerosis Awareness Month. In honor of this month, the Multiple Sclerosis Association of America (MSAA) is hosting a number of educational events and programs to educate and spread awareness about MS.

MSAA invites you to join Elizabeth Crabtree-Hartman, MD for a live webinar titled, Helpful Tools for MS Relapse Management on Tuesday, March 13 from 8:00 PM – 9:00 PM EST as part of our MS Awareness Month activities.

During this one-hour webinar, Dr. Crabtree-Hartman will provide members of the MS community with a more thorough understanding of MS relapses, discuss ways to improve patient-doctor communication, explain MS relapse treatment options, help lessen the confusion around pseudoexacerbations, and more. Dr. Crabtree-Hartman will also give viewers the chance to engage in a Q&A session from emails submitted through the webinar’s live chat feature.

More info on relapses

Relapses, also referred to as exacerbations, attacks, flare-ups, episodes, or bouts, are experienced by most people diagnosed with multiple sclerosis (MS). When someone experiences a relapse, he or she may be having new symptoms or an increase in existing symptoms. Relapses occur with relapsing-remitting, progressive-relapsing, and sometimes secondary-progressive forms of MS. Relapses do not occur with primary-progressive MS, although individuals may experience day-to-day fluctuations in how they feel.

Sign up now for MSAA’s Relapse Management webinar, and be sure to visit MSAA’s website during the month of March for more activities related to MS Awareness Month.

Join MSAA's MS Awareness Month live webinar, Helpful Tools for MS Relapse Management

By providing your email address, you are agreeing to our privacy policy. We never sell or share your email address.

More on this topic

This article represents the opinions, thoughts, and experiences of the author; none of this content has been paid for by any advertiser. The team does not recommend or endorse any products or treatments discussed herein. Learn more about how we maintain editorial integrity here.

Join the conversation

or create an account to comment.